Global senolytic drugs market is anticipated to grow with an impressive CAGR value in the mentioned forecast years 2023-2027 on the account of increasing demand for the anti-aging pharmaceuticals and therapeutics. Increase in the advancement of the pharmaceutical products that have the ability to increase healthy lifespan is further driving the growth of the global senolytic drugs market in the upcoming five years.

Senolytic drugs are the pharmaceutical products or a class of drugs that is targeted over the senescent cells and destroys them with their effects. Senescence is a biological process in which cells age but do not divide to create daughter cells and also don’t die. In sometime these cells start to accumulate and form a tumor like structure inside the human body. Senescence is not only responsible for a human body to grow old but may also cause development of cancer and other diseases. Skin wrinkling, weaker eyesight, weaker hearing capacity are some of the major examples of senescence that causes old age in humans.

Increasing Demand For Anti-Aging Products Drive Market Growth

Increasing demand for the anti-aging drugs and pharmaceutical products that kills the senescent cells to increase healthy lifespan of the human beings, is driving the growth of the global senolytic drugs market in the upcoming five years. Also, rising geriatric population in the world is also supporting the growth of the global senolytic drugs market in the next five years.

According to the United Nations Department of Economic and Social Affairs, Population Division, the number of people aged 65 years or above was 702.9 million in 2019. This number is expected to grow by 120% and reach 1548.9 million by 2050.

Increasing Chronic Diseases Drive Market Growth

Senescent cells are linked to the increasing cases of age-related diseases. Increasing instances of diseases like cataract, glaucoma, neurodegenerative diseases (Alzheimer and Parkinson), cardiovascular diseases (CVD, atherosclerosis, and hypertension), idiopathic pulmonary fibrosis (IPF), diabetes type II, sarcopenia, osteoarthritis, osteoporosis, chronic obstructive pulmonary disease (COPD), and certain types of tumors, are majorly responsible for the growing demand for senolytic drugs to decrease the risks of such chronic diseases, thus substantiate the growth of the global senolytic drugs market in the future five years.

According to Center for Disease Control and Prevention, Heart disease is the leading cause of death for men, women, and people of most racial and ethnic groups in the United States. One person dies every 36 seconds in the United States from cardiovascular disease. About 659,000 people in the United States die from heart disease each year—that’s 1 in every 4 deaths.


Click here to download the sample

Market Segmentation

The global senolytic drugs market segmentation is based on type, application, distribution channel, regional distribution, and competitive landscape. Based on type, the market is fragmented into FOXO4-related peptides, bcl-2 Family Inhibitors, Src Tyrosine Kinase Inhibitors, Navitoclax, Dasatinib & Quercetin, and others. Market segmentation based on application, bifurcates into longevity, senescence inhibition, cardiovascular diseases, neural degenerative diseases, and others.

On the basis of distribution channel, the market is sub-segmented into retail pharmacies, hospital pharmacies, and online pharmacies. The market analysis also studies the regional segmentation to devise regional market segmentation, divided among Asia-Pacific region, North American region, European region, South American region, and Middle East & African region.

Company Profile

AgeX Therapeutics, Inc., Cleara Biotech, Eternans Ltd., FoxBio Inc., Numeric Biotech, T.A. Sciences, Inc., Recursion Pharmaceuticals, Inc, are enlisted in a partial list of major market players of the global senolytic drugs market. The existing market players are highly invested in research and product development along with viable service provisions for the consumers. New market entrants may follow similar strategies along with merger and acquisition methods for future brand establishment.

Attribute

Details

Base Year

2021

Historical Data

2017 – 2020

Estimated Year

2022

Forecast Period

2023 – 2027

Quantitative Units

Revenue in USD Million, and CAGR for 2017-2021 and 2022-2027

Report coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments covered

  • Type
  • Application
  • Distribution Channel

Regional scope

North America; Europe; Asia Pacific; South America; Middle East & Africa

Country scope

United States, Mexico, Canada, China, India, Japan, South Korea, Australia, Germany, France, United Kingdom, Spain, Italy, South Africa, UAE, Saudi Arabia, Brazil, Argentina, Colombia

Key companies profiled

AgeX Therapeutics, Inc., Cleara Biotech, Eternans Ltd., FoxBio Inc., Numeric Biotech, T.A. Sciences, Inc., Recursion Pharmaceuticals, Inc

Customization scope

10% free report customization with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Delivery Format

PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

 

Report Scope:

In this report, global senolytic drugs market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Senolytic Drugs Market, By Type:
    • FOXO4-related peptides
    • bcl-2 Family Inhibitors
    • Src Tyrosine Kinase Inhibitors
    • Navitoclax
    • Dasatinib & Quercetin
    • Others
  • Senolytic Drugs Market, By Application:
    • Longevity
    • Senescence Inhibition
    • Cardiovascular Diseases
    • Neural Degenerative Diseases
    • Others
  • Senolytic Drugs Market, By Distribution Channel:
    • Retail Pharmacies
    • Hospital Pharmacies
    • Online Pharmacies
  • Senolytic Drugs Market, By Region:
    • North America
      • United States
      • Mexico
      • Canada
    • Europe
      • France
      • Germany
      • United Kingdom
      • Italy
      • Spain
    • Asia-Pacific
      • China
      • India
      • Japan
      • South Korea
      • Australia
    • Middle East & Africa
      • South Africa
      • Saudi Arabia
      • UAE
    • South America
      • Brazil
      • Argentina
      • Colombia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global senolytic drugs market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).
Global Senolytic Drugs Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at sales@techsciresearch.com

In case you don’t find what you are looking for, please get in touch with our custom research team at sales@techsciresearch.com

1.    Product Overview

2.    Research Methodology

3.    Impact of COVID-19 on Global Senolytic Drugs Market

4.    Executive Summary

5.    Voice of Customer

5.1.  Preference, By Type

5.2.  Factors Contributing to Demand for Senolytic Drugs

5.3.  Barriers to Adoption of Senolytic Drugs

5.4.  Brand Awareness

6.    Clinical Trials

6.1.  Ongoing Clinical Trials

6.2.  Completed Clinical Trials

6.3.  Terminated Clinical Trials

6.4.  Clinical Trial Analysis

7.    Patent Analysis

7.1.  Patent Granted (2016-2020)

7.2.  Patent Applications Filed

8.    Global Senolytic Drugs Market Outlook

8.1.  Market Size & Forecast

8.1.1.     By Value

8.2.  Market Share & Forecast

8.2.1.     By Type (FOXO4-related peptides, bcl-2 Family Inhibitors, Src Tyrosine Kinase Inhibitors, Navitoclax, Dasatinib & Quercetin, Others)

8.2.2.     By Application (Longevity, Senescence Inhibition, Cardiovascular Diseases, Neural Degenerative Diseases, Others)

8.2.3.     By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies)

8.2.4.     By Company (2020)

8.2.5.     By Region

8.3.  Product Market Map

9.    North America Senolytic Drugs Market Outlook

9.1.  Market Size & Forecast          

9.1.1.     By Value

9.2.  Market Share & Forecast

9.2.1.     By Type

9.2.2.     By Application

9.2.3.     By Distribution Channel

9.2.4.     By Country

9.3.  North America: Country Analysis

9.3.1.     United States Senolytic Drugs Market Outlook

9.3.1.1.         Market Size & Forecast

9.3.1.1.1.             By Value

9.3.1.2.         Market Share & Forecast

9.3.1.2.1.             By Type

9.3.1.2.2.             By Application

9.3.1.2.3.             By Distribution Channel

9.3.2.     Mexico Senolytic Drugs Market Outlook

9.3.2.1.         Market Size & Forecast

9.3.2.1.1.             By Value

9.3.2.2.         Market Share & Forecast

9.3.2.2.1.             By Type

9.3.2.2.2.             By Application

9.3.2.2.3.             By Distribution Channel

9.3.3.     Canada Senolytic Drugs Market Outlook

9.3.3.1.         Market Size & Forecast

9.3.3.1.1.             By Value

9.3.3.2.         Market Share & Forecast

9.3.3.2.1.             By Type

9.3.3.2.2.             By Application

9.3.3.2.3.             By Distribution Channel

10.  Europe Senolytic Drugs Market Outlook

10.1.              Market Size & Forecast

10.1.1.  By Value

10.2.              Market Share & Forecast

10.2.1.  By Type

10.2.2.  By Application

10.2.3.  By Distribution Channel

10.2.4.  By Country

10.3.              Europe: Country Analysis

10.3.1.  France Senolytic Drugs Market Outlook

10.3.1.1.      Market Size & Forecast

10.3.1.1.1.           By Value

10.3.1.2.      Market Share & Forecast

10.3.1.2.1.           By Type

10.3.1.2.2.           By Application

10.3.1.2.3.           By Distribution Channel

10.3.2.  Germany Senolytic Drugs Market Outlook

10.3.2.1.      Market Size & Forecast

10.3.2.1.1.           By Value

10.3.2.2.      Market Share & Forecast

10.3.2.2.1.           By Type

10.3.2.2.2.           By Application

10.3.2.2.3.           By Distribution Channel

10.3.3.  United Kingdom Senolytic Drugs Market Outlook

10.3.3.1.      Market Size & Forecast

10.3.3.1.1.           By Value

10.3.3.2.      Market Share & Forecast

10.3.3.2.1.           By Type

10.3.3.2.2.           By Application

10.3.3.2.3.           By Distribution Channel

10.3.4.  Italy Senolytic Drugs Market Outlook

10.3.4.1.      Market Size & Forecast

10.3.4.1.1.           By Value

10.3.4.2.      Market Share & Forecast

10.3.4.2.1.           By Type

10.3.4.2.2.           By Application

10.3.4.2.3.           By Distribution Channel

10.3.5.  Spain Senolytic Drugs Market Outlook

10.3.5.1.      Market Size & Forecast

10.3.5.1.1.           By Value

10.3.5.2.      Market Share & Forecast

10.3.5.2.1.           By Type

10.3.5.2.2.           By Application

10.3.5.2.3.           By Distribution Channel

11.  Asia-Pacific Senolytic Drugs Market Outlook

11.1.              Market Size & Forecast

11.1.1.  By Value

11.2.              Market Share & Forecast

11.2.1.  By Type

11.2.2.  By Application

11.2.3.  By Distribution Channel

11.2.4.  By Country

11.3.              Asia-Pacific: Country Analysis

11.3.1.  China Senolytic Drugs Market Outlook

11.3.1.1.      Market Size & Forecast

11.3.1.1.1.           By Value

11.3.1.2.      Market Share & Forecast

11.3.1.2.1.           By Type

11.3.1.2.2.           By Application

11.3.1.2.3.           By Distribution Channel

11.3.2.  India Senolytic Drugs Market Outlook

11.3.2.1.      Market Size & Forecast

11.3.2.1.1.           By Value

11.3.2.2.      Market Share & Forecast

11.3.2.2.1.           By Type

11.3.2.2.2.           By Application

11.3.2.2.3.           By Distribution Channel

11.3.3.  South Korea Senolytic Drugs Market Outlook

11.3.3.1.      Market Size & Forecast

11.3.3.1.1.           By Value

11.3.3.2.      Market Share & Forecast

11.3.3.2.1.           By Type

11.3.3.2.2.           By Application

11.3.3.2.3.           By Distribution Channel

11.3.4.  Japan Senolytic Drugs Market Outlook

11.3.4.1.      Market Size & Forecast

11.3.4.1.1.           By Value

11.3.4.2.      Market Share & Forecast

11.3.4.2.1.           By Type

11.3.4.2.2.           By Application

11.3.4.2.3.           By Distribution Channel

11.3.5.  Australia Senolytic Drugs Market Outlook

11.3.5.1.      Market Size & Forecast

11.3.5.1.1.           By Value

11.3.5.2.      Market Share & Forecast

11.3.5.2.1.           By Type

11.3.5.2.2.           By Application

11.3.5.2.3.           By Distribution Channel

12.  South America Senolytic Drugs Market Outlook

12.1.              Market Size & Forecast

12.1.1.  By Value

12.2.              Market Share & Forecast

12.2.1.  By Type

12.2.2.  By Application

12.2.3.  By Distribution Channel

12.2.4.  By Country

12.3.              South America: Country Analysis

12.3.1.  Brazil Senolytic Drugs Market Outlook

12.3.1.1.      Market Size & Forecast

12.3.1.1.1.           By Value

12.3.1.2.      Market Share & Forecast

12.3.1.2.1.           By Type

12.3.1.2.2.           By Application

12.3.1.2.3.           By Distribution Channel

12.3.2.  Argentina Senolytic Drugs Market Outlook

12.3.2.1.      Market Size & Forecast

12.3.2.1.1.           By Value

12.3.2.2.      Market Share & Forecast

12.3.2.2.1.           By Type

12.3.2.2.2.           By Application

12.3.2.2.3.           By Distribution Channel

12.3.3.  Colombia Senolytic Drugs Market Outlook

12.3.3.1.      Market Size & Forecast

12.3.3.1.1.           By Value

12.3.3.2.      Market Share & Forecast

12.3.3.2.1.           By Type

12.3.3.2.2.           By Application

12.3.3.2.3.           By Distribution Channel

13.  Middle East and Africa Senolytic Drugs Market Outlook

13.1.              Market Size & Forecast

13.1.1.  By Value

13.2.              Market Share & Forecast

13.2.1.  By Type

13.2.2.  By Application

13.2.3.  By Distribution Channel

13.2.4.  By Country

13.3.              MEA: Country Analysis

13.3.1.  South Africa Senolytic Drugs Market Outlook

13.3.1.1.      Market Size & Forecast

13.3.1.1.1.           By Value

13.3.1.2.      Market Share & Forecast

13.3.1.2.1.           By Type

13.3.1.2.2.           By Application

13.3.1.2.3.           By Distribution Channel

13.3.2.  Saudi Arabia Senolytic Drugs Market Outlook

13.3.2.1.      Market Size & Forecast

13.3.2.1.1.           By Value

13.3.2.2.      Market Share & Forecast

13.3.2.2.1.           By Type

13.3.2.2.2.           By Application

13.3.2.2.3.           By Distribution Channel

13.3.3.  UAE Senolytic Drugs Market Outlook

13.3.3.1.      Market Size & Forecast

13.3.3.1.1.           By Value

13.3.3.2.      Market Share & Forecast

13.3.3.2.1.           By Type

13.3.3.2.2.           By Application

13.3.3.2.3.           By Distribution Channel

14.  Market Dynamics

14.1.              Drivers

14.2.              Challenges

15.  Market Trends & Developments

16.  Competitive Landscape

16.1.              AgeX Therapeutics, Inc.

16.2.              Cleara Biotech

16.3.              Eternans Ltd.

16.4.              FoxBio Inc

16.5.              Numeric Biotech

16.6.              T.A. Sciences, Inc.

16.7.              Recursion Pharmaceuticals, Inc.

17.  Strategic Recommendations

18.  About Us & Disclaimer

In case you don’t find what you are looking for, please get in touch with our custom research team at sales@techsciresearch.com